http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
최성원(SW Choi),정욱(W Jeong),백용찬(YC Baik),지정희(CH Chi),김철(C Kim) 대한산부인과학회 1987 Obstetrics & Gynecology Science Vol.30 No.8
저자들은 최근 17세인 미산부에서 발생한 혼합성배세표종(mixed germ cell tumor)의 1예를 경험하였기에 문헌적 고찰과 함께 보고하는 바이다. a case of malignant mixed cell tumor in 17 years old unmarried woman, is presented with a brief review of concerned literature.
( Do Kang ),( Hs Seo ),( Bg Choi ),( Cw Choi ),( Eunmi Lee ),( Jp Kim ),( Sk Lee ),( Si Lim ),( Sw Kim ),( Jo Na ),( Cu Choi ),( He Lim ),( Jw Kim ),( Ej Kim ),( S-w Rha ),( Cg Park ),( Dj Oh ) 대한내과학회 2013 대한내과학회 추계학술대회 Vol.2013 No.1
Objectives: Statins for the prevention of CVD are known to be as diabetogenic. However most clinical trials suggested that current statin therapy in moderate to high cardiovascular risk should not be changed, due to the outwheighing benefits of statins on CVD prevention. We investigated which clinical variables on treatment are most closely associated with the development of 24 month MACE (all death, any myocardial infarction and target vessel revascularization) in DES implanted patients on statin therapy. Methods: Total 299 patients undergone DES implantation with taking statins for secondary prevention were involved. Tracking the development of MACE within 24 month post-PCI, 12 month follow up clinical variables showing significant correlation to the event were evaluated. To discover whether the changes in clinical parameters over the 12 month follow up are associated with the event development, subtractions from baseline to follow up lab results and absolute value conversion of the subtractions are obtained. Variables showing significant difference between the groups were put into the multivariate analysis and into the survival curve model. Results: Fasting glucose at 12 month were significantly higher in the event group. Subtractions from baseline to 12 month follow up showed no significant differences between the groups, however, absolute change in fasting glucose revealed a significant difference. In multivariate analysis, absolute change in fasting glucose greater than 17 mg/dL/year was strongly associated with the event development. When study population was further divided into four groups by using IQR of absolute change in fasting glucose, greater absolute change during 12 month post-PCI showed a higher risk of 24 month MACE development in both multivariate analysis and survival curve models. Conclusion: The findings suggest that greater absolute change in fasting glucose during 12 month post-PCI is an independent risk factor for 24 month MACE development in DES implanted patients on statin therapy. Relative glucose control impairment described as absolute change in fasting glucose in the current study might be responsible for the development of 24 month MACE.
최규홍,박성욱,신훈범,유미정 대한산부인과학회 1996 Obstetrics & Gynecology Science Vol.39 No.11
Uterine myomas are observed in pregnancy more frequently now than in the past because many women are delaying childbearing to their late ages, the time of greatest risk myoma growth. Although most myoma remain asymptomatic, they may complicate the course of pregnancy. Some authors have ascribed to uterine myoma an increased incidence of abortion, ectopic pregnancy, premature rupture of membrane, preterm delivery, abruptio placentae, red degeneration, fetal malpresentation, postpartum hemorrhage, postpartum fever, fetal growth retardation, cesarean delivery, and cesarean hysterectomy. In this study, we evaluated uterine myoma for ultrasound-documented size, type, location, and relation to the placenta, and related these findings to complications caused by myomas during pregnancy, at delivery, and in the postpartum. The results were as follows: 1. The mean(±standard deviation) maternal ages were 31.5±4.4 and 31.2±3.9 years in the myoma and control groups, respectively, a nonsignificant difference. Seventy five of the myoma patients(43.9%) were in their first pregnancy and 92(56.1%) were at least in their second; 1722 controls(42.3%) were nulliparous and 2350(57.7%) were multiparous, also a nonsignificant difference. 2. Delivery was recorded in 148(90.2%) and 3763(92.4%) of the subjects in the myoma and control groups, respectively, and abortion in 16(9.8%) and 309(7.6%), neither significantly different. 3. Threatened abortion was recorded in 18.2% and 10.3% of the subjects in the myoma and control groups, respectively, and preterm delivery in 16.9% and 9.5%, both significantly different. 4. Premature rupture of membrane was recorded in 7.4% and 7.0% of the subjects in the myoma and control groups, respectively, and fetal growth retardation in 13.5% and 10.2%, neither significantly different. 5. Abruptio placentae was redorded in 6.0% and 0.5% of the subjects in the myoma and control groups, respectively, and pelvic pain in 15.5% and 1.2%, both significantly different. 6. Hysterectomies at delivery were recorded in 3.4% and 0.08% of the subjects in the both groups, respectively, a significant difference. 7. Postpartum fever was recorded in 5.4% and 0.6% of the subjects in the both groups, respectively, a significant difference. 8. Placenta abruption was more recorded in size $gt;200cm3 of myoma mass(33.3%), in submucosal type of myoma mass(38.5%), in subjects of the placenta covered over myoma mass(22.2%), respectively, a significant difference. 9. Pelvic pain was more recorded in size $gt;200 cm3 of myoma mass(61.5%), in myoma mass was located at fundus or isthmus of the uterus(41.2%, 33.3%), respectively, a significant difference.